404
+1-313-307-4176
sales@stratviewresearch.com
Vascular Access Device Market Report
Vascular Access Device Market Size, Share, Trend, Forecast, & Industry Analysis: 2022-2028
Vascular Access Device Market is segmented By Device Type (Central Vascular Access Devices, Peripheral Vascular Access Devices), By End Use (Hospitals, Clinics and Ambulatory Care Centers), and Region - COVID-19 Impact Analy...
The Vascular Access Device market is projected to grow from USD 3.98 billion in 2021 to USD 6.44 billion by 2028 at a CAGR of over 7.04% during the forecast period of 2022-2028.
Vascular access devices are referred to as medical equipment’s which are used to ingress the bloodstream to administer fluids, supply medicines, nutritional components, and collection of blood vessels and their products. These vascular access tubes are made from silicon, latex, and other substances.
Rapidly growing incidence of lifestyle diseases across the globe and technological developments in medical therapies are likely to boost the market growth. Also, the surge in the number of chemotherapy procedures on account of soaring cancer cases worldwide further augments product usage. Moreover, vascular access devices are being widely used in pediatric patients further offering immense growth opportunities to the industry players.
The COVID-19 pandemic has moderately affected the vascular access device industry. The rapid spread of COVID-19 has led to several thousands of hospital admissions. The focus of healthcare professionals has been shifted toward the treatment of COVID-19-infected patients, which affected the treatment of non-emergency medical conditions, amid the pandemic.
Key players operating in the vascular access device market are-
Based on device type, the global vascular access device market has been classified into central vascular access devices and peripheral vascular access devices. Under these, the central vascular access devices segment held the largest market share in 2021 and is likely to grow at a considered CAGR during the forecast period. Central vascular access devices are being extensively used in chemotherapy as well as for the treatment of cardiovascular & chronic kidney disorders, thus bolstering the segment growth.
By region, the North American market held a significant market share in 2021 and is projected to grow at a healthy CAGR in the coming years. Rising healthcare expenditure, favorable reimbursement scenario, as well as a growing number of product approvals is likely to boost the market growth in the region. Also, a surge in the number of cancer cases and the growing prevalence of cardiovascular diseases further augments the regional market growth.
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
Here is the list of the group of customers that the vascular access device market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
The vascular access device market is expected to witness an impressive growth of 7.04% CAGR in 2028.
BD (US), C.R.Bard (US), Teleflex (US), Smiths Medical (US), B Braun (Germany), Angiodynam-ics (US), Terumo (Japan), Nipro (Japan), Edwards (US), and Amecath (US) are among the key players in the market.
The vascular access device market size is expected to reach USD 6.44 billion in 2028.
The central vascular access devices segment held the largest share of the market in 2021.
North America is expected to grow at a healthy CAGR in the market in the next five years.
Vascular Access Device companies, Vascular Access Device distributors, Medical companies, Government organizations are the target audience in the market.
WE ACCEPT
